OC advises General Atlantic on IT, IP and data protection law regarding strategic partnership with ControlExpert International legal practice Osborne Clarke has advised General Atlantic on IT, IP and data protection related aspects of its strategic partnership with ControlExpert GmbH. General Atlantic will, amongst others, strategically support the company’s growth...

The Court of Justice of the European Union (‘CJEU’) recently handed down judgment in the case of C More v. Sandberg, in which it was asked to consider whether the EU Infosoc Directive precludes the broad protection offered by the Swedish Copyright Law in terms of the right the Swedish...

For many companies intellectual property rights form a large part of their assets. This can be the patent that protects the main product of a company, the specific design that differentiates a product from its competitors, a trademark which through hard work and lots of marketing finally stands for more...

Trade mark law and practice in the European Union will be revamped over the next few years as the EU’s three legislative bodies, the Commission, the Parliament and the Council, have agreed final compromise texts for: (a) a new replacement Trade Mark Directive, which partially harmonises trade mark law and...

A report of our Patent Strategies round table event on 30th June 2015 Once the preserve of R&D departments and a specialist group of patent attorneys, patents have hit the headlines over the last decade not only through the high profile litigation between mobile phone companies but also through the...

The proprietor of a standard-essential patent (SEP) may be obliged to refrain from enforcing his patent or bringing patent-infringement proceedings if he has undertaken to grant licences to third parties on FRAND terms (Fair, Reasonable and Non-Discriminatory) and does not comply with this obligation. The patent infringer who is willing...

In February 2015, a partnership of European pharmaceutical industry associations including EFPIA, the EGA and others has set up the European Medicines Verification Organisation (“EMVA”), to oversee the Europe-wide deployment of the European Standards Model to verify the authenticity of individual packs of medicinal products at the point where they...

Otsuka Pharmaceuticals Company applied to the Intellectual Property Office for a six month extension to the Supplementary Protection Certificate for its Abilify® (aripiprazole) treatment for schizophrenia and bipolar disorder under Article 36 of the Paediatric Regulation (Regulation (EC) No. 1901/2006), on the grounds that it had completed studies in accordance...